CytoDyn (CYDY) Other Non-Current Liabilities (2014 - 2026)

CytoDyn's Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $43.6 million for Q1 2026.

• Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $43.6 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $43.6 million (changed 0.0% YoY) and the FY2025 annual result came in at $43.6 million, changed 0.0% from the prior year.
• Other Non-Current Liabilities was $43.6 million for Q1 2026 at CytoDyn, roughly flat from $43.6 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $43.6 million in Q2 2024 and bottomed at $33000.0 in Q4 2023.
• A 4-year average of $29.7 million and a median of $43.6 million in 2024 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities soared 131933.33% — and 2025, when it changed 0.0%.
• CytoDyn's Other Non-Current Liabilities stood at $33000.0 in 2023, then surged by 131933.33% to $43.6 million in 2024, then changed by 0.0% to $43.6 million in 2025, then changed by 0.0% to $43.6 million in 2026.
• Business Quant data shows CYDY's Other Non-Current Liabilities at $43.6 million in Q1 2026, $43.6 million in Q4 2025, and $43.6 million in Q3 2025.